» Articles » PMID: 33679725

Serum Amyloid A in Inflammatory Rheumatic Diseases: A Compendious Review of a Renowned Biomarker

Overview
Journal Front Immunol
Date 2021 Mar 8
PMID 33679725
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Serum amyloid A (SAA) is an acute phase protein with a significant importance for patients with inflammatory rheumatic diseases (IRD). The central role of SAA in pathogenesis of IRD has been confirmed by recent discoveries, including its involvement in the activation of the inflammasome cascade and recruitment of interleukin 17 producing T helper cells. Clinical utility of SAA in IRD was originally evaluated nearly half a century ago. From the first findings, it was clear that SAA could be used for evaluating disease severity and monitoring disease activity in patients with rheumatoid arthritis and secondary amyloidosis. However, cost-effective and more easily applicable markers, such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), overwhelmed its use in clinical practice. In the light of emerging evidences, SAA has been discerned as a more sensitive biomarker in a wide spectrum of IRD, especially in case of subclinical inflammation. Furthermore, a growing number of studies are confirming the advantages of SAA over many other biomarkers in predicting and monitoring response to biological immunotherapy in IRD patients. Arising scientific discoveries regarding the role of SAA, as well as delineating SAA and its isoforms as the most sensitive biomarkers in various IRD by recently developing proteomic techniques are encouraging the revival of its clinical use. Finally, the most recent findings have shown that SAA is a biomarker of severe Coronavirus disease 2019 (COVID-19). The aim of this review is to discuss the SAA-involving immune system network with emphasis on mechanisms relevant for IRD, as well as usefulness of SAA as a biomarker in various IRD. Therefore, over a hundred original papers were collected through an extensive PubMed and Scopus databases search. These recently arising insights will hopefully lead to a better management of IRD patients and might even inspire the development of new therapeutic strategies with SAA as a target.

Citing Articles

Balancing inflammation: the specific roles of serum amyloid A proteins in sterile and infectious diseases.

Mohanty T, Milicevic K, Gothert H, Tillmann A, Padra M, Papareddy P Front Immunol. 2025; 16:1544085.

PMID: 40061939 PMC: 11885894. DOI: 10.3389/fimmu.2025.1544085.


Integrated Clinomics and Molecular Dynamics Simulation Approaches Reveal the SAA1.1 Allele as a Biomarker in Alkaptonuria Disease Severity.

Trezza A, Roncaglia B, Visibelli A, Barletta R, Peruzzi L, Marzocchi B Biomolecules. 2025; 15(2).

PMID: 40001497 PMC: 11853296. DOI: 10.3390/biom15020194.


Recent Advances in Studies of Serum Amyloid A: Implications in Inflammation, Immunity and Tumor Metastasis.

Chang Y, Liu Y, Zou Y, Ye R Int J Mol Sci. 2025; 26(3).

PMID: 39940756 PMC: 11817213. DOI: 10.3390/ijms26030987.


Old and New Biomarkers in Idiopathic Recurrent Acute Pericarditis (IRAP): Prognosis and Outcomes.

Mascolo R, Bizzi E, Martelli M, Facoetti C, Colazzo G, Barone F Curr Cardiol Rep. 2025; 27(1):17.

PMID: 39798014 PMC: 11724782. DOI: 10.1007/s11886-024-02170-y.


Acute phase proteins patterns as biomarkers in bacterial infection: Recent insights.

Al Ali A, Darwish W Open Vet J. 2024; 14(10):2539-2550.

PMID: 39545194 PMC: 11560262. DOI: 10.5455/OVJ.2024.v14.i10.4.


References
1.
Lozanski G, Jiang S, Samols D, Kushner I . C-reactive protein and serum amyloid A mRNA stability following induction by cytokines. Cytokine. 1996; 8(7):534-40. DOI: 10.1006/cyto.1996.0072. View

2.
Lingwood D, Binnington B, Rog T, Vattulainen I, Grzybek M, Coskun U . Cholesterol modulates glycolipid conformation and receptor activity. Nat Chem Biol. 2011; 7(5):260-2. DOI: 10.1038/nchembio.551. View

3.
Seok A, Lee H, Lee S, Lee J, Mun S, Park A . Identification and Validation of SAA4 as a Rheumatoid Arthritis Prescreening Marker by Liquid Chromatography Tandem-mass Spectrometry. Molecules. 2017; 22(5). PMC: 6154608. DOI: 10.3390/molecules22050805. View

4.
Cheng N, He R, Tian J, Ye P, Ye R . Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J Immunol. 2008; 181(1):22-6. PMC: 2464454. DOI: 10.4049/jimmunol.181.1.22. View

5.
Migita K, Koga T, Satomura K, Izumi M, Torigoshi T, Maeda Y . Serum amyloid A triggers the mosodium urate -mediated mature interleukin-1β production from human synovial fibroblasts. Arthritis Res Ther. 2012; 14(3):R119. PMC: 3446500. DOI: 10.1186/ar3849. View